Are you interested in learning how to leverage non-dilutive funding to advance your health and biomedical research? Through its Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding opportunities, the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health can help.
Register today to join NCATS, Life Science Washington, New Mexico Biotechnology and Biomedical Association, Oregon Bioscience Association and Montana BioScience Alliance on November 14 for a webinar on programs and funding that support small businesses and technology transfer organizations. The presentation will feature:
- SBIR and STTR program overview
- Benefits of NCATS funding
- Tips for submitting a successful application
- Key NCATS focus areas to advance clinical research and translational sciences
- Upcoming opportunities and deadlines
- Other resources and programs, including NCATS’ Therapeutics for Rare and Neglected Diseases and Bridging Interventional Development Gaps
Who Should Attend
Individuals representing the following groups are encouraged to participate:
- Small biotech and/or healthcare technology businesses
- Women-owned small businesses and entrepreneurs from socially and economically disadvantaged backgrounds
- Academic and research institutions
- Technology transfer organizations
- Multiple venture-backed small businesses
Featured Speaker
Lili M. Portilla, M.P.A., Director, Strategic Alliances, NCATS, NIH, U.S. Department of Health and Human Services
NCATS’ SBIR and STTR programs are engines of innovation for developing and commercializing tools, technologies and intervention platforms to support the creation of new therapeutics and diagnostics. SBIR and STTR are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.
